Journal article

Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy

PA Cohen, Y Leung, L Anderson, R van der Griend, P Chivers, S Bilic, S Bittinger, A Brand, MK Bulsara, J Codde, L Eva, L Farrell, D Harker, U Herbst, S Jeffares, D Loh, O McNally, GR Mohan, T Nicholson, A Powell Show all

Gynecologic Oncology | Published : 2020

Abstract

Objective: Adenocarcinoma in situ (AIS) of the cervix is a precursor to cervical adenocarcinoma. When AIS is detected by cervical screening an excision biopsy is mandatory to exclude invasion. We aimed to compare margins status, specimen size and fragmentation after loop electrosurgical excision procedure (LEEP) and ‘cold knife cone biopsy’ (CKC). Methods: The EXCISE Trial was an investigator-initiated, multicenter, open-label, parallel-group, phase 2, randomized study. Patients were enrolled at seven hospitals in Australia and New Zealand. We randomly assigned women aged ≥18 to ≤45 years with screen detected AIS to LEEP or CKC. Co-primary endpoints were margin status, specimen size and frag..

View full abstract

University of Melbourne Researchers